Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
FASEB J ; 15(3): 571-3, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11259370

ABSTRACT

Nitric oxide is a crucial mediator of several forms of glomerulonephritis. We examined the effects of NO on the mRNA expression pattern in glomerular mesangial cells by using a low-stringency reverse transcriptase-polymerase chain reaction method and detected a cDNA fragment that was induced by interleukin 1b (IL-1b) and further up-regulated by the NO donor diethylenetriamine-nitric oxide (DETA-NO). Each respective cDNA fragment was found to match with the cDNAs of rat macrophage inflammatory protein 2 (MIP-2) and GRO/cytokine-induced neutrophil chemoattractant 2b (CINC-2b). Further characterization of MIP-2 regulation by Northern blot analysis confirmed an NO- and IL-1b-dependent increase in MIP-2 mRNA levels. Moreover, inhibition of IL-1b-induced endogenous NO formation by the NO-synthase (NOS) inhibitor L-NMMA markedly attenuated MIP-2 protein expression. We cloned 770 bp of the 5'-flanking region of rat MIP-2 and fused this fragment to a luciferase reporter gene. Transfection of the construct into mesangial cells resulted in a 3.5-fold increase in luciferase activity in cells treated with DETA-NO when compared to controls, suggesting a transcriptional mechanism for NO-induced MIP-2 expression. Deletion and mutational analysis identified critical nuclear factor (NF)-kB and NF-IL-6 binding sites required for NO regulation of MIP-2. In vivo, inhibition of NO synthesis in the Thy-1.1 model of mesangioproliferative glomerulonephritis by the specific inducible-NOS inhibitor L-NIL resulted in a marked reduction of MIP-2 mRNA expression. Furthermore, infiltration of neutrophils into the glomerulus was dramatically attenuated in L-NIL-treated rats.


Subject(s)
Chemokines/genetics , Glomerular Mesangium/metabolism , Glomerulonephritis/metabolism , Kidney Glomerulus/metabolism , Nitric Oxide/metabolism , Amidines/pharmacology , Animals , Benzylamines/pharmacology , Chemokine CXCL2 , Chemokines/metabolism , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/genetics , Genes, Reporter , Glomerular Mesangium/cytology , Glomerulonephritis/genetics , Glomerulonephritis/pathology , Interleukin-1/metabolism , Lysine/analogs & derivatives , Lysine/pharmacology , Mutagenesis, Site-Directed , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Promoter Regions, Genetic/genetics , Rats , Recombinant Fusion Proteins/metabolism
2.
Life Sci ; 69(25-26): 2945-55, 2001 Nov 09.
Article in English | MEDLINE | ID: mdl-11758822

ABSTRACT

Inflammatory glomerular diseases are accompanied by changes in the expression patterns of growth factors, mediators and matrix-associated proteins in mesangial cells and by the production of nitric oxide via the cytokine-inducible form of the nitric oxide synthase. Nitric oxide has been shown to act potently on gene transcription. To identify genes that are differentially expressed by endogenously produced nitric oxide, we forced rat mesangial cells to produce high amounts of nitric oxide by exposure to inflammatory cytokines and compared the mRNA expression patterns of cytokine-stimulated mesangial cells with cells that were additionally treated with the nitric oxide synthase inhibitor L-NMMA to block endogenous NO synthesis. We used a modification of a low stringency RT-PCR approach designated as RNA arbitrarily-primed polymerase chain reaction (RAP-PCR). In this way, we identified among others the integrin-linked kinase (ILK) as an NO-regulated gene. The NO-mediated changes in the mRNA and protein expression patterns of ILK were compared to that of "secreted protein acidic and rich in cystein" (SPARC), a gene that was identified as NO-regulated in the same set of experiments (Walpen et al., J. Am. Soc. Nephrol., 11, 468-476). ILK and SPARC mRNA levels by were downregulated by cytokines via endogenously produced nitric oxide in a comparable manner as verified by Northern blot analysis. In contrast, cytokine- induced NO production or administration of exogenous NO-donors strongly reduced SPARC protein levels without altering ILK protein content in mesangial cells over a period up to 72 hours. Blocking de novo protein synthesis showed a short halflife of SPARC (< 2 hours) whereas ILK-protein was stable over a period of 7 hours, indicating that NO-mediated reduction of ILK mRNA levels does not influence protein content of ILK in mesangial cells under the time limitations given under cell culture conditions. However, a role for cytokines/NO in ILK-long-term regulation in chronic inflammatory diseases that may influence phenotypic responses such as apoptosis or cell proliferation remains to be elucidated.


Subject(s)
Glomerular Mesangium/drug effects , Nitric Oxide/pharmacology , Protein Serine-Threonine Kinases/genetics , RNA, Messenger/biosynthesis , Animals , Blotting, Northern , Blotting, Western , Cells, Cultured , DNA Primers/chemistry , Down-Regulation , Gene Expression Regulation, Enzymologic , Glomerular Mesangium/enzymology , Humans , Interleukin-1/pharmacology , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Osteonectin/genetics , Osteonectin/metabolism , Protein Serine-Threonine Kinases/metabolism , Rats , Recombinant Proteins , Reverse Transcriptase Polymerase Chain Reaction , omega-N-Methylarginine/pharmacology
3.
J Immunol ; 165(10): 5788-97, 2000 Nov 15.
Article in English | MEDLINE | ID: mdl-11067938

ABSTRACT

The modulation of cell signaling by free radicals is important for the pathogenesis of inflammatory diseases. Recently, we have shown that NO reduces IL-1beta-induced matrix metalloproteinase (MMP-9) expression in glomerular mesangial cells (MC). Here we report that exogenously administrated superoxide, generated by the hypoxanthine/xanthine oxidase system (HXXO) or by the redox cycler 2, 3-dimethoxy-1,4-naphtoquinone, caused a marked amplification of IL-1beta-primed, steady state, MMP-9 mRNA level and an increase in gelatinolytic activity in the conditioned medium. Superoxide generators alone were ineffective. Cytokine-induced steady state mRNA levels of TIMP-1, an endogenous inhibitor of MMP-9, were affected similarly by HXXO. Transient transfection of rat mesangial cells with 0.6 kb of the 5'-flanking region of the rat MMP-9 gene proved a transcriptional regulation of MMP-9 expression by superoxide. HXXO augmented the IL-1beta-triggered nuclear translocation of p65 and c-Jun and, in parallel, increased DNA binding activities of NF-kappaB and AP-1. Mutation of either response element completely prevented MMP-9 promoter activation by IL-1beta. Moreover, specific inhibitors of the classical extracellular signal-regulated kinase (ERK) pathway and p38 mitogen-activated protein kinase (MAPK) cascade, partially reversed the HXXO-mediated effects on MMP-9 mRNA levels, thus demonstrating involvement of ERKs and p38 MAPKs in MMP-9 expression. Furthermore, IL-1beta-triggered phosphorylation of all three MAPKs, including p38-MAPK, c-Jun N-terminal kinase, and ERK, was substantially enhanced by superoxide. Our data identify superoxide as a costimulatory factor amplifying cytokine-induced MMP-9 expression by interfering with the signaling cascades leading to the activation of AP-1 and NF-kappaB.


Subject(s)
Glomerular Mesangium/enzymology , Glomerular Mesangium/immunology , I-kappa B Proteins , Interleukin-1/physiology , MAP Kinase Signaling System/immunology , Matrix Metalloproteinase 9/biosynthesis , NF-kappa B/physiology , Superoxides/pharmacology , Transcription Factor AP-1/physiology , Adjuvants, Immunologic/pharmacology , Animals , Base Sequence , Binding Sites/genetics , Binding Sites/immunology , Biological Transport/immunology , Cell Nucleus/immunology , Cell Nucleus/metabolism , DNA-Binding Proteins/metabolism , Enzyme Activation/drug effects , Enzyme Activation/immunology , Enzyme Inhibitors/pharmacology , Flavonoids/pharmacology , Gene Amplification/immunology , Gene Expression Regulation/immunology , Glomerular Mesangium/cytology , Glomerular Mesangium/metabolism , Hydrolysis , Imidazoles/pharmacology , JNK Mitogen-Activated Protein Kinases , MAP Kinase Signaling System/drug effects , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinase Inhibitors , Mitogen-Activated Protein Kinases/metabolism , Molecular Sequence Data , NF-KappaB Inhibitor alpha , NF-kappa B/antagonists & inhibitors , NF-kappa B/metabolism , Phosphorylation , Promoter Regions, Genetic/immunology , Pyridines/pharmacology , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/biosynthesis , RNA, Messenger/metabolism , Rats , Tissue Inhibitor of Metalloproteinase-1/biosynthesis , Tissue Inhibitor of Metalloproteinase-1/genetics , Transcription Factor AP-1/metabolism , Transcription Factor RelA
4.
Kidney Int ; 57(1): 59-69, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10620188

ABSTRACT

UNLABELLED: Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. BACKGROUND: High-output levels of nitric oxide (NO) are produced by rat mesangial cells (MCs) in response to proinflammatory cytokines such as interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) by the inducible isoform of NO synthase (iNOS). We tested modulatory effects of NO on the expression and activities of matrix metalloproteinases-9 and -2 (MMP-9 and MMP-2), respectively. Temporal and spatial expression of these MMPs and their specific inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), seems to be critical in the extensive extracellular matrix (ECM) remodeling that accompanies sclerotic processes of the mesangium. Methods and Results. Using the NO donors S-Nitroso-N-acetyl-D,L-penicillamine (SNAP) and DETA-NONOate, we found strong inhibitory effects of NO mainly on the IL-1beta-induced MMP-9 mRNA levels. NO on its own had only weak effects on the expression of MMP-9 and MMP-2. The addition of the NOS inhibitor NG-monomethyl L-arginine (L-NMMA) dose dependently increased steady-state mRNA levels of cytokine-induced MMP-9, suggesting that endogenously produced NO exerts tonic inhibition of MMP-9 expression. MMP-9 activity in conditioned media from MCs costimulated with IL-1beta and NO donor contained less gelatinolytic activity than media of cells treated with IL-1beta alone. Exogenously added NO did not alter gelatinolytic activity of MMP-9 in cell-free zymographs. The expression levels of TIMP-1 were affected by NO similarly to the expression of MMP-9. CONCLUSION: We conclude that NO modulates cytokine-mediated expression of MMP-9 and TIMP-1 in rat MCs in culture. Our results provide evidence that NO-mediated attenuation of MMP-9 gelatinolytic activity is primarily due to a reduced expression of MMP-9 mRNA, and not the result of direct inhibition of enzymatic activity.


Subject(s)
Glomerular Mesangium/enzymology , Matrix Metalloproteinase 9/genetics , Nitric Oxide/physiology , Animals , Base Sequence , Cyclic GMP/metabolism , DNA Primers , Down-Regulation , Electrophoresis, Polyacrylamide Gel , Enzyme Inhibitors/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Glomerular Mesangium/drug effects , Glomerular Mesangium/metabolism , Interleukin-1/pharmacology , Nitric Oxide/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Tissue Inhibitor of Metalloproteinase-1/genetics , omega-N-Methylarginine/pharmacology
5.
FEBS Lett ; 435(1): 35-8, 1998 Sep 11.
Article in English | MEDLINE | ID: mdl-9755854

ABSTRACT

Exposure of mesangial cells to superoxide, generated by the hypoxanthine/xanthine oxidase system or by the redox cycler 2,3-dimethoxy-1,4-naphthoquinone caused a concentration-dependent amplification of interleukin (IL)-1beta-stimulated nitrite production. The effect of superoxide was accompanied by an increase in inducible nitric oxide synthase (iNOS) protein and iNOS mRNA levels. Incubation of mesangial cells with superoxide alone did not induce iNOS expression. To elucidate whether the increase of iNOS expression is due to transcriptional upregulation we fused a 4.5-kb genomic iNOS fragment that contains the transcriptional start site of the rat iNOS gene to a luciferase reporter gene. In transient transfection studies, superoxide caused a 10-fold augmentation of iNOS promoter activity in IL-1beta-challenged mesangial cells. Our data identify superoxide as a co-stimulatory factor amplifying cytokine-induced iNOS gene expression and subsequent nitric oxide (NO) synthesis.


Subject(s)
Glomerular Mesangium/enzymology , Interleukin-1/pharmacology , Nitric Oxide Synthase/biosynthesis , Superoxides/pharmacology , Animals , Drug Synergism , Enzyme Induction/drug effects , Enzyme Induction/genetics , Glomerular Mesangium/cytology , Glomerular Mesangium/metabolism , Humans , Mice , Nitric Oxide/physiology , Nitric Oxide Synthase/drug effects , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type II , Promoter Regions, Genetic/physiology , Rats , Reactive Oxygen Species/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...